Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?

被引：22

作者：

Fontana, RJ ^{[1
]}

Lok, ASF ^{[1
]}

机构：

[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI USA

来源：

JOURNAL OF HEPATOLOGY | 2000年 / 33卷 / 02期

关键词：

D O I：

10.1016/S0168-8278(00)80376-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：329 / 332

页数：4

共 35 条

[1] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[2]

CHANG TT, 2000, ANTIVIR THER S, V5, P44

[3] PROGNOSTIC VALUE OF CHILD-TURCOTTE CRITERIA IN MEDICALLY TREATED CIRRHOSIS [J].

CHRISTENSEN, E ;

SCHLICHTING, P ;

FAUERHOLDT, L ;

GLUUD, C ;

ANDERSEN, PK ;

JUHL, E ;

POULSEN, H ;

TYGSTRUP, N .

HEPATOLOGY, 1984, 4 (03) :430-435

[4] The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss [J].

de Man, RA ;

Bartholomeusz, AI ;

Niesters, HGM ;

Zondervan, PE ;

Locarnini, SA .

JOURNAL OF HEPATOLOGY, 1998, 29 (04) :669-675

[5] SURVIVAL AND PROGNOSTIC INDICATORS IN HEPATITIS-B SURFACE ANTIGEN-POSITIVE CIRRHOSIS OF THE LIVER [J].

DEJONGH, FE ;

JANSSEN, HLA ;

DEMAN, RA ;

HOP, WCJ ;

SCHALM, SW ;

VANBLANKENSTEIN, M .

GASTROENTEROLOGY, 1992, 103 (05) :1630-1635

[6] Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

[7] Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy [J].

Donato, F ;

Tagger, A ;

Chiesa, R ;

Ribero, ML ;

Tomasoni, V ;

Fasola, M ;

Gelatti, U ;

Portera, G ;

Boffetta, P ;

Nardi, G .

HEPATOLOGY, 1997, 26 (03) :579-584

[8] INFLUENCE OF HEPATITIS-DELTA-VIRUS INFECTION ON PROGRESSION TO CIRRHOSIS IN CHRONIC HEPATITIS TYPE-B [J].

FATTOVICH, G ;

BOSCARO, S ;

NOVENTA, F ;

PORNARO, E ;

STENICO, D ;

ALBERTI, A ;

RUOL, A ;

REALDI, G .

JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) :931-935

[9] Is lamivudine beneficial in HBSAG plus patients awaiting liver transplantation? Experience in 182 North American patients. [J].

Fontana, RJ ;

Keeffe, EB ;

Soldevila, C ;

Lilly, L ;

Luketic, V ;

Kowdley, K ;

Adams, P ;

Jensen, D ;

Bacon, B ;

Wright, T ;

Conjeevaram, HS ;

Perrillo, R ;

Dickson, R ;

Brown, RS ;

Randall-Ray, A ;

Richtmyer, P ;

Lok, ASF .

TRANSPLANTATION, 1999, 67 (07) :S16-S16

[10] Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine [J].

Gauthier, J ;

Bourne, EJ ;

Lutz, MW ;

Crowther, LM ;

Dienstag, JL ;

Brown, NA ;

Condreay, LD .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :1757-1762

← 1 2 3 4 →